NORRY ELLIOT (Chief Medical Officer) sold 42.6% of their position (5.58K shares) of ADAPTIMMUNE THERAPEUTICS PLC on the open market
Open‑market sale worth $3.2K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/17/2025ACC: 0001104659-25-004608
Officer· Chief Medical Officer
Since Jan 2020
-5.58K
Net shares
Net seller
$3.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
5.58K disposed
Non-Derivative Transactions1
American Depositary Shares representing Ordinary Shares
Direct
Shares
−5.58K
Price / share
$0.58
Trade value
$3.24K
% of position
42.6%
1/17/2025
13.09K→7.51K
Total
Net shares
−5.58K
Net value
-$3.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| American Depositary Shares representing Ordinary Shares Direct | 1/17/2025 | S · Sale | −5.58K | $0.58 | $3.24K | 42.6% | 13.09K | 7.51K |
| Total | −5.58K | -$3.24K | ||||||
Derivative Transactions0
No derivative transactions reported